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SIEWPOINT305Comparing the Benefits of Post-MI Cellular Transplantation to Other Therapieshorsten Reffelmann, Stephanie Könemann, Robert A. Kloner
ntracoronary transplantation of peripheral blood- or bone marrow-derived cells is associated
ith moderate increases in left ventricular ejection fraction and decreases in end-systolic
olumes. Although there is substantial variability between trials, meta-analyses suggest an
ncrease in ejection fraction of 3% to 4% with cellular therapy compared with control groups.
effelmann and colleagues review the data for several other widely accepted treatments for
cute myocardial infarction (MI), such as thrombolysis, angiotensin-converting enzyme
nhibitors, and beta-blockers, and finds that the effects on cardiac remodeling are in the range
f effects seen with these cellular therapies.CLINICAL RESEARCH NTERVENTIONAL CARDIOLOGY309Thrombus Aspiration During STEMI Reduces Infarct Sizeennaro Sardella, Massimo Mancone, Chiara Bucciarelli-Ducci, Luciano Agati, Raffaele Scardala,
acopo Carbone, Marco Francone, Angelo Di Roma, Giulia Benedetti, Giulia Conti, Francesco Fedele
islodgement of thrombus during primary percutaneous coronary intervention (PPCI) can
ead to microvascular obstruction and limit tissue reperfusion despite an open infarct-related
rtery. Sardella and colleagues randomized almost 200 ST-segment elevation myocardial
nfarction (STEMI) patients to either standard PPCI or to use of a manual thrombectomy
evice prior to PPCI. Thrombus aspiration was associated with improved myocardial blush
rade and ST-segment resolution. Thrombus aspiration also reduced infarct size and was
ssociated with a lower incidence of cardiac death during follow-up. Thrombus aspiration
ay reduce distal thrombus embolization and help to preserve microvascular integrity during
TEMI.(continued on page A-18)
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rORONARY DISEASE RISK316Reducing Non–HDL-C Reduces Cardiac Risk, Regardless of Methodennifer G. Robinson, Songfeng Wang, Brian J. Smith, Terry A. Jacobson
on–high-density lipoprotein cholesterol (HDL-C), which measures circulating levels of the
therogenic apolipoprotein B-containing lipoproteins, may be a superior predictor of
ardiovascular risk compared with low-density lipoprotein cholesterol, but less is known about
he relationship between non–HDL reduction and coronary heart disease (CHD) risk
eduction. Robinson and colleagues performed a meta-analysis of studies that used fibrates,
iacin, bile acid sequestrants, ileal bypass surgery, or statins to reduce non–HDL. For statins,
1% decrease in non–HDL-C was associated with a relative risk decrease of 1%. Results
ppear to be similar for other lipid-modifying drugs used as monotherapy. Non–HDL-C
ppears to be an important target of therapy for CHD prevention, with a 1% reduction
esulting in an approximately 1% reduction in cardiac risk.ORONARY DISEASE RISK323Persistently Impaired Endothelial Function Increases Cardiac RiskEditorial Comment
Peter Ganz and Priscilla Y. Hsue,oshinobu Kitta, Jyun-ei Obata, Takamitsu Nakamura, Mitsumasa Hirano, Yasushi Kodama,
aisuke Fujioka, Yukio Saito, Ken-ichi Kawabata, Keita Sano, Tsuyoshi Kobayashi, Toshiaki Yano,
azuto Nakamura, Kiyotaka Kugiyama
ndothelial dysfunction is an established predictor of cardiovascular risk, but it is unclear if
mproving endothelial function can reduce the risk of future events. Kitta and colleagues
erformed flow-mediated dilation (FMD) assessments on 251 subjects with atherosclerosis.
ubjects were then treated for risk factor modification and FMD was repeated 6 months
ater. FMD was persistently impaired in 41% of patients after 6 months. Cardiac events were
.5 times more likely to occur in patients with persistently impaired FMD. These results
uggest that serial FMD testing may be superior to a single assessment for predicting
ardiac risk.EART FAILURE334Seattle Heart Failure Model May Underestimate Risk in Advanced HFEditorial Commentndreas P. Kalogeropoulos, Vasiliki V. Georgiopoulou, Grigorios Giamouzis, Andrew L. Smith,
yed A. Agha, Sana Waheed, Sonjoy Laskar, John Puskas, Sandra Dunbar, David Vega,
ayne C. Levy, Javed Butler
he Seattle Heart Failure Model (SHFM) provides prognostic information for patients with
eart failure (HF); it was developed from clinical trial databases and published data.
alogeropoulos and colleagues studied the accuracy of the SHFM in over 400 patients
eferred for possible cardiac transplantation. The SHFM underestimated absolute risk in this
ohort (observed vs. predicted event rate: 11% vs. 9% at 1 year and 28% vs. 23% at 3 years).
isk underprediction was more prominent in patients with an implantable device and in black
atients. In patients with advanced HF, the SHFM offers adequate discrimination of high
isk versus low risk, but underestimates absolute risk.(continued on page A-20)
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iARDIAC IMAGING345Absolute CAC More Accurate Than Age-Gender-Race/Ethnicity-Adjusted PercentileEditorial Comment
François Shiele andatthew J. Budoff, Khurram Nasir, Robyn L. McClelland, Robert Detrano, Nathan Wong,
oger S. Blumenthal, George Kondos, Richard A. Kronmal
any centers now report an age-gender-race/ethnicity-adjusted percentile score for coronary
rtery calcium (CAC) to adjust for the typically higher levels seen in males and the elderly.
udoff and colleagues reviewed CAC scores and clinical outcomes to determine if these
ercentiles predict cardiovascular risk better than the absolute CAC score. Both methods
obustly predicted risk, with a hazard ratio (HR) of 16 for a score 90th percentile and an
R 20 for an Agatston score 400. The area under the curve for the absolute score was
igher than for the adjusted percentiles. The authors conclude that patients with low absolute
cores are low risk, regardless of their percentile rank, whereas those with a CAC score 400
re high risk regardless of the percentile.ARDIAC RESYNCHRONIZATION THERAPY355More Frequent Pacing Improves CRT OutcomesEditorial Commentruce A. Koplan, Andrew J. Kaplan, Stan Weiner, Paul W. Jones, Milan Seth, Shelly A. Christman
oplan and colleagues sought to determine whether or not patients with cardiac
esynchronization therapy (CRT) devices have improved outcomes when the ventricular
acing percentage is at or near 100% compared with those with less frequent pacing. The
ecords of almost 2,000 subjects enrolled in clinical trials were reviewed. Subjects paced at
3% to 100% (quartiles 2 to 4) had a 44% reduction in the combined end point of
ospitalization for heart failure and mortality compared to those with 92% pacing. CRT
ppears to be most effective when biventricular pacing occurs 92% of the time, and
trategies to increase this percentage may be efficacious.FROM AROUND
THE WORLDOCUS ON CHINA363Additive Risks Between Tobacco Exposure and MetS in Chinese Subjectsao He, Tai Hing Lam, Bin Jiang, Jie Wang, Xiaoyong Sai, Li Fan, Xiaoying Li, Yinhe Qin, Frank B. Hu
ore than 72% of all Chinese (600 million people) are regularly exposed to tobacco smoke,
ither actively or passively, and almost one-half of elderly Chinese meet criteria for the
etabolic syndrome (MetS). He and colleagues randomly sampled urban, elderly Chinese
ubjects to study the interactions among MetS, tobacco exposure, and cardiovascular disease
CVD). Compared with never smokers without MetS, the risk of CVD in subjects with
etS was 1.8 times higher in never smokers and 3.5 times higher in current smokers. In
omen, the risk of CVD nearly doubled with either secondhand smoke exposure or MetS,
nd was 3 times higher in women with both. The combination of tobacco smoke exposure
nd MetS substantially increases the risk of CVD; current trends suggest a dramatic increase
n CVD in China.
